Before market open, Recursion disclosed in a tersely worded regulatory filing with the Securities and Exchange Commission (SEC) that it was taking a series of measures to streamline its operations.

Recursion Pharmaceuticals said on Tuesday it would lay off about 20% of its workforce as the biotech company tries to cope with an industry-wide funding crunch and the current policy uncertainty.

Recursion Pharmaceuticals is laying off a fifth of its workforce in connect with a previously announced streamlining of the AI biotech’s pipeline.

As of March 31, Recursion Pharmaceuticals had a cash position of $509 million. Following Tuesday’s layoffs, the biotech expects its runway to last into the fourth quarter of 2027.

MIT and Recursion partner for AI drug discovery tool Freely available Boltz-2 algorithm can predict small-molecule binding affinities by Laura Howes ...

The word “Schlieren” is German, and translates roughly to “streaks”. What is streaky photography, and why might you want to use it in a project? And where did this funny term come from?… ...

Recursion Halts Four Pipeline Programs, Sharpening Cancer, Rare Disease Focus AI drug developer advances fourth Sanofi-partnered program, earns $7M milestone payment ...

"Recursion's decade-long investment in AI is driving a decisive, data-led portfolio strategy," said Chris Gibson, Co-Founder and CEO of Recursion. "We are prioritizing high-potential programs to ...

Recursion is scheduled to report its first quarter 2025 financial results, providing transparency and updates to investors, which can enhance trust and investor relations.

AlgoBuddy is an interactive tool for visualizing graph algorithms and recursion trees. It supports BFS, DFS, Dijkstra, Topological Sorting, Fibonacci, Longest Common Subsequence, and more, with ...